# Influenza Antiviral DAS-181-F04 in Healthy Adults

> **NCT01651494** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 9 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** DAS181
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01651494
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-12
- **Primary completion:** 2012-09-18
- **Final completion:** 2012-09-18
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651494, "Influenza Antiviral DAS-181-F04 in Healthy Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01651494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*